Literature DB >> 32193870

Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.

Mostafa Nazari1, Isaac Shiri2, Ghasem Hajianfar3, Niki Oveisi4, Hamid Abdollahi5, Mohammad Reza Deevband6, Mehrdad Oveisi3,7, Habib Zaidi8,9,10,11.   

Abstract

PURPOSE: To identify optimal classification methods for computed tomography (CT) radiomics-based preoperative prediction of clear cell renal cell carcinoma (ccRCC) grade.
MATERIALS AND METHODS: Seventy-one ccRCC patients (31 low grade and 40 high grade) were included in this study. Tumors were manually segmented on CT images followed by the application of three image preprocessing techniques (Laplacian of Gaussian, wavelet filter, and discretization of the intensity values) on delineated tumor volumes. Overall, 2530 radiomics features (tumor shape and size, intensity statistics, and texture) were extracted from each segmented tumor volume. Univariate analysis was performed to assess the association between each feature and the histological condition. Multivariate analysis involved the use of machine learning (ML) algorithms and the following three feature selection algorithms: the least absolute shrinkage and selection operator, Student's t test, and minimum Redundancy Maximum Relevance. These selected features were then used to construct three classification models (SVM, random forest, and logistic regression) to discriminate high from low-grade ccRCC at nephrectomy. Lastly, multivariate model performance was evaluated on the bootstrapped validation cohort using the area under the receiver operating characteristic curve (AUC) metric.
RESULTS: The univariate analysis demonstrated that among the different image sets, 128 bin-discretized images have statistically significant different texture parameters with a mean AUC of 0.74 ± 3 (q value < 0.05). The three ML-based classifiers showed proficient discrimination between high and low-grade ccRCC. The AUC was 0.78 for logistic regression, 0.62 for random forest, and 0.83 for the SVM model, respectively.
CONCLUSION: CT radiomic features can be considered as a useful and promising noninvasive methodology for preoperative evaluation of ccRCC Fuhrman grades.

Entities:  

Keywords:  Computed tomography (CT); Fuhrman grading; Machine learning; Radiomics; Renal cell carcinoma

Year:  2020        PMID: 32193870     DOI: 10.1007/s11547-020-01169-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  31 in total

1.  CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors.

Authors:  Giulia Benedetti; Martina Mori; Marta Maria Panzeri; Maurizio Barbera; Diego Palumbo; Carla Sini; Francesca Muffatti; Valentina Andreasi; Stephanie Steidler; Claudio Doglioni; Stefano Partelli; Marco Manzoni; Massimo Falconi; Claudio Fiorino; Francesco De Cobelli
Journal:  Radiol Med       Date:  2021-02-01       Impact factor: 3.469

2.  Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should assess MR features.

Authors:  Vincenza Granata; Roberta Grassi; Roberta Fusco; Sergio Venanzio Setola; Andrea Belli; Alessandro Ottaiano; Guglielmo Nasti; Michelearcangelo La Porta; Ginevra Danti; Salvatore Cappabianca; Carmen Cutolo; Antonella Petrillo; Francesco Izzo
Journal:  Radiol Med       Date:  2021-11-29       Impact factor: 3.469

3.  Delta radiomics: a systematic review.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Luca Boldrini; Giovanna Vacca; Emma D'Ippolito; Salvatore Annunziata; Alessandra Farchione; Maria Paola Belfiore; Isacco Desideri; Salvatore Cappabianca
Journal:  Radiol Med       Date:  2021-12-04       Impact factor: 3.469

4.  Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Giovanna Vacca; Giuliana Giacobbe; Antonio Angrisani; Alfredo Clemente; Ginevra Danti; Pierpaolo Correale; Salvatore Francesco Carbone; Luigi Pirtoli; Lorenzo Bianchi; Angelo Vanzulli; Cesare Guida; Roberto Grassi; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

Review 5.  Radiomics in medical imaging: pitfalls and challenges in clinical management.

Authors:  Roberta Fusco; Vincenza Granata; Giulia Grazzini; Silvia Pradella; Alessandra Borgheresi; Alessandra Bruno; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Andrea Giovagnoni; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2022-03-28       Impact factor: 2.701

Review 6.  Radiomics to better characterize small renal masses.

Authors:  Teele Kuusk; Joana B Neves; Maxine Tran; Axel Bex
Journal:  World J Urol       Date:  2021-01-26       Impact factor: 4.226

7.  Radiomics-based neural network predicts recurrence patterns in glioblastoma using dynamic susceptibility contrast-enhanced MRI.

Authors:  Ka Young Shim; Sung Won Chung; Jae Hak Jeong; Inpyeong Hwang; Chul-Kee Park; Tae Min Kim; Sung-Hye Park; Jae Kyung Won; Joo Ho Lee; Soon-Tae Lee; Roh-Eul Yoo; Koung Mi Kang; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn; Kyu Sung Choi; Seung Hong Choi
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

8.  Less is More: Intelligent Intensive Care for SARS-CoV-2 Based on the Imaging Data.

Authors:  Hamid Abdollahi
Journal:  J Med Imaging Radiat Sci       Date:  2020-04-18

9.  Uncontrolled Confounders May Lead to False or Overvalued Radiomics Signature: A Proof of Concept Using Survival Analysis in a Multicenter Cohort of Kidney Cancer.

Authors:  Lin Lu; Firas S Ahmed; Oguz Akin; Lyndon Luk; Xiaotao Guo; Hao Yang; Jin Yoon; A Aari Hakimi; Lawrence H Schwartz; Binsheng Zhao
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

Review 10.  Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma.

Authors:  Vincenza Granata; Roberta Grassi; Roberta Fusco; Andrea Belli; Carmen Cutolo; Silvia Pradella; Giulia Grazzini; Michelearcangelo La Porta; Maria Chiara Brunese; Federica De Muzio; Alessandro Ottaiano; Antonio Avallone; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2021-07-19       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.